[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  Celltrion Inc. Celltrion's Eydenzelt (biosimilar Eylea) secures FDA approval, opening access to a $X billion market. Abpro and Celltrion present preclinical data for ABP-102/CT-P72 at AACR 2025, showing promise in HER2-positive cancer treatment. ### About Celltrion Inc. Celltrion Inc. is a South Korean biopharmaceutical company. ### Price: $ [#](/topic/$068270ks/close) ---  [Price 24-Hour Time-Series Raw Data](/topic/$068270ks/time-series/close.tsv) The price is expected to increase due to positive news around FDA approval, high sentiment, and Celltrion Holdings securing fresh funding, despite a lack of current market cap data. **1-Year High**: $XXXXXXX on 2024-12-18 **1-Year Low**: $XXXXXXX on 2025-05-12 ### AltRank: undefined [#](/topic/$068270ks/alt_rank) ---  [AltRank 24-Hour Time-Series Raw Data](/topic/$068270ks/time-series/alt_rank.tsv) Celltrion Inc. is currently AltRank #undefined based on combined combined social and market metrics **Daily Average**: XXX **1-Year High**: XXXXX on 2024-10-31 **1-Year Low**: XXX on 2025-02-26 ### Galaxy Score: XX [#](/topic/$068270ks/galaxy_score) ---  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$068270ks/time-series/galaxy_score.tsv) **Current Value**: XX **Daily Average**: XX **1-Year High**: XX on 2024-11-15 **1-Year Low**: X on 2025-07-23 ### Engagements: XXXXX [#](/topic/$068270ks/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$068270ks/time-series/interactions.tsv) **Current Value**: XXXXX **Daily Average**: XXXXX **1 Week**: XXXXXX -XX% **1 Month**: XXXXXXX +92% **6 Months**: XXXXXXXXX +35% **1 Year**: XXXXXXXXX +28% **1-Year High**: XXXXXX on 2025-06-08 **1-Year Low**: XXX on 2025-02-22 | Social Network | TikTok | X | News | Reddit | YouTube | | -------------- | ------ | - | ---- | ------ | ------- | | Engagements | XXX | XXXXX | X | XX | XXX | ### Mentions: XX [#](/topic/$068270ks/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$068270ks/time-series/posts_active.tsv) **Current Value**: XX **Daily Average**: XX **1 Month**: XXX -XX% **6 Months**: XXXXX +26% **1 Year**: XXXXX +424% **1-Year High**: XXX on 2025-08-13 **1-Year Low**: X on 2024-10-21 | Social Network | TikTok | X | News | Reddit | YouTube | | -------------- | ------ | - | ---- | ------ | ------- | | Mentions | XX | XX | X | X | XX | ### Creators: XX [#](/topic/$068270ks/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$068270ks/time-series/contributors_active.tsv) XX unique social accounts have posts mentioning Celltrion Inc. in the last XX hours which is down XX% from XX in the previous XX hours **Daily Average**: XX **1 Month**: XX -XX% **6 Months**: XXX +50% **1 Year**: XXX +208% **1-Year High**: XXX on 2025-07-23 **1-Year Low**: X on 2025-01-27 The most influential creators that mention Celltrion Inc. in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@JS_stockwatch](/creator/twitter/JS_stockwatch) | X | XXXXX | X | XX | | [@dliepau](/creator/tiktok/dliepau) | X | XXXXX | X | XX | | [@RachelRachet](/creator/twitter/RachelRachet) | X | XXXXX | X | XX | | [@Celltrioninc](/creator/twitter/Celltrioninc) | X | XXX | X | XX | | [@maybecha777](/creator/tiktok/maybecha777) | X | XXX | X | X | | [@Philip__Went](/creator/twitter/Philip__Went) | X | XXXXX | X | X | | [@ej23ny](/creator/twitter/ej23ny) | X | XXXXX | X | X | [View More](/list/creators/$068270ks/100) ### Sentiment: XX% [#](/topic/$068270ks/sentiment) ---  [Sentiment 24-Hour Time-Series Raw Data](/topic/$068270ks/time-series/sentiment.tsv) **Current Value**: XX% **Daily Average**: XX% **1 Week**: XXX% no change **1 Month**: XX% -X% **6 Months**: XX% -X% **1 Year**: XX% -XX% **1-Year High**: XXX% on 2024-10-25 **1-Year Low**: XX% on 2025-02-03 **Most Supportive Themes** - **FDA Approval:** (30%) Celltrion's Yuflyma gains FDA interchangeability, expanding market potential. - **US Biosimilar Expansion:** (20%) Changes in US drug pricing could increase access to affordable medicines. - **Partnership With Abpro:** (15%) Celltrion is investing and partnering with Abpro. **Most Critical Themes** - **Engagement Decline & Negative Sentiment:** (16%) Social media interest is declining, with a decrease in engagement. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | TikTok | XXX | X% | XXX | XX% | XX | X% | | X | XXX | X% | XXXXX | XX% | X | X% | | News | X | X% | X | X% | X | X% | | Reddit | XX | X% | XX | X% | X | X% | | YouTube | X | X% | XXX | X% | X | X% | | | | | | | | | | Total | XXX | XX% | XXXXX | XX% | XX | X% | ### Market Cap: $undefined [#](/topic/$068270ks/market_cap) ---  [Market Cap 24-Hour Time-Series Raw Data](/topic/$068270ks/time-series/market_cap.tsv) **Current Value**: $undefined **Daily Average**: $XXXXXXXXXXXXXXXXXX **1-Year High**: $XXXXXXXXXXXXXXXXXX on 2024-12-18 **1-Year Low**: $XXXXXXXXXXXXXXXXXX on 2024-11-13 **Top assets mentioned** In the posts about Celltrion Inc. in the last XX hours [Eli Lilly and Company (LLY)](/topic/eli-lilly) [Innovative Solutions & Support (ISSC)](/topic/$issc) [Amgen, Inc. (AMGN)](/topic/$amgn) [Bitcoin Incognito (XBI)](/topic/$xbi) [Piper Sandler Companies (PIPR)](/topic/$pipr) [Gilead Sciences, Inc. (GILD)](/topic/gilead-sciences) [Thermo Fisher Scientific Inc. (TMO)](/topic/$tmo) [Unilever plc (UL)](/topic/$ul) [ServiceNow Inc (NOW)](/topic/servicenow) [Sanofi (SNY)](/topic/sanofi) **Top topics mentioned** In the posts about Celltrion Inc. in the last XX hours [$abp](/topic/$abp), [skincare](/topic/skincare), [united states](/topic/united-states), [stocks healthcare](/topic/stocks-healthcare), [eli](/topic/eli), [eli lilly](/topic/eli-lilly), [stocks](/topic/stocks), [dual](/topic/dual), [approved](/topic/approved), [investment](/topic/investment), [japan](/topic/japan), [has been](/topic/has-been), [liquid](/topic/liquid), [money](/topic/money), [launches](/topic/launches), [ronald](/topic/ronald), [realworld](/topic/realworld), [$issc](/topic/$issc), [$156m](/topic/$156m), [$175bn](/topic/$175bn), [$vape](/topic/$vape), [$330m](/topic/$330m), [momentum](/topic/momentum), [balance sheet](/topic/balance-sheet), [$amgn](/topic/$amgn), [canada](/topic/canada), [south korea](/topic/south-korea), [targets](/topic/targets), [rachel](/topic/rachel), [stocks technology](/topic/stocks-technology), [$091990kq](/topic/$091990kq), [kosdaq](/topic/kosdaq), [iv](/topic/iv), [price in](/topic/price-in), [faster](/topic/faster), [lang](/topic/lang), [cancel](/topic/cancel), [kung](/topic/kung), [kami](/topic/kami), [milky](/topic/milky), [abc news](/topic/abc-news), [dubai](/topic/dubai), [demi](/topic/demi), [$idx](/topic/$idx), [$pme](/topic/$pme), [$pmeax](/topic/$pmeax), [the only](/topic/the-only), [future of](/topic/future-of), [billion dollar](/topic/billion-dollar), [ipo](/topic/ipo), [$175b](/topic/$175b), [$30m](/topic/$30m), [$xbi](/topic/$xbi), [half of](/topic/half-of), [$wint](/topic/$wint), [$pipr](/topic/$pipr), [spotlight](/topic/spotlight), [hasan](/topic/hasan), [insider](/topic/insider), [victor](/topic/victor), [lisa](/topic/lisa), [nasdaq](/topic/nasdaq), [discussions](/topic/discussions), [korea](/topic/korea), [malaysia](/topic/malaysia), [covid19](/topic/covid19), [gilead sciences](/topic/gilead-sciences), [$tmo](/topic/$tmo), [$4519t](/topic/$4519t), [$15m](/topic/$15m), [$atnf](/topic/$atnf), [alan](/topic/alan), [$439b](/topic/$439b), [$abcl](/topic/$abcl), [australia](/topic/australia), [samsung](/topic/samsung), [paris](/topic/paris), [dedication](/topic/dedication), [titan](/topic/titan), [long term](/topic/long-term), [upside](/topic/upside), [corporate finance](/topic/corporate-finance), [$ul](/topic/$ul), [$ulvrl](/topic/$ulvrl), [stocks consumer defensive](/topic/stocks-consumer-defensive), [servicenow](/topic/servicenow), [sanofi](/topic/sanofi), [$azn](/topic/$azn), [$mrk](/topic/$mrk), [$nvda](/topic/$nvda), [$apld](/topic/$apld), [$robo](/topic/$robo), [breakthrough](/topic/breakthrough), [save the](/topic/save-the), [#ai](/topic/#ai), [united states dollar](/topic/united-states-dollar), [$abbv](/topic/$abbv), [$pfe](/topic/$pfe), [danny](/topic/danny), [vida](/topic/vida) ### Top Social Posts [#](/topic/$068270ks/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "The World's Most Innovative Companies of 2025 X. ServiceNow X. Workday X. Salesforce X. Tesla X. Amazon X. Netflix X. Incyte X. Unilever X. Naver XX. Facebook XX. Monster XX. Unilever Indonesia XX. Adobe XX. Celltrion XX. Autodesk XX. Regeneron XX. Vertex XX. AmorePacific XX. Concora XX. Illumina XX. Marriott International XX. Alexion XX. CP All XX. Red Hat XX. Tencent Source: Forbes" [X Link](https://x.com/TheDataHubX/status/1979786817135394945) [@TheDataHubX](/creator/x/TheDataHubX) 2025-10-19T05:48Z 17.9K followers, 7109 engagements "Hansoh and Leads Biolabs bag global outlicensing deals. Chugais partner Lilly announced positive P3 result for orforglipron. Celltrion launched Actemra biosimilar in US" [X Link](https://x.com/Generic_Tina/status/1979707871999983865) [@Generic_Tina](/creator/x/Generic_Tina) 2025-10-19T00:35Z XX followers, XX engagements "$ABP closed XXXXXX (+0.85%) vol 880.3K. The HER2CD3 bispecific engager ABP-102 shows best-in-class potential and Abpros strategic collaboration with Celltrion underpins its early-stage value narrative. Strategy postedclick to access full layout:" [X Link](https://x.com/JS_stockwatch/status/1979694757313122594) [@JS_stockwatch](/creator/x/JS_stockwatch) 2025-10-18T23:43Z XXX followers, XX engagements "$ABP strengthens biotech partnerships 🚀🚀🚀 Collaborations with Celltrion and other global pharma firms expand Abpros reach in antibody co-development and commercialization. 👉Only insiders get alerts join before it spikes 🔗" [X Link](https://x.com/EgrandeBilli/status/1979352875915710480) [@EgrandeBilli](/creator/x/EgrandeBilli) 2025-10-18T01:04Z XXX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Celltrion Inc.
Celltrion's Eydenzelt (biosimilar Eylea) secures FDA approval, opening access to a $X billion market. Abpro and Celltrion present preclinical data for ABP-102/CT-P72 at AACR 2025, showing promise in HER2-positive cancer treatment.
About Celltrion Inc.
Celltrion Inc. is a South Korean biopharmaceutical company.
Price: $ #
Price 24-Hour Time-Series Raw Data
The price is expected to increase due to positive news around FDA approval, high sentiment, and Celltrion Holdings securing fresh funding, despite a lack of current market cap data.
1-Year High: $XXXXXXX on 2024-12-18
1-Year Low: $XXXXXXX on 2025-05-12
AltRank: undefined #
AltRank 24-Hour Time-Series Raw Data
Celltrion Inc. is currently AltRank #undefined based on combined combined social and market metrics
Daily Average: XXX
1-Year High: XXXXX on 2024-10-31
1-Year Low: XXX on 2025-02-26
Galaxy Score: XX #
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2024-11-15
1-Year Low: X on 2025-07-23
Engagements: XXXXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXX +92%
6 Months: XXXXXXXXX +35%
1 Year: XXXXXXXXX +28%
1-Year High: XXXXXX on 2025-06-08
1-Year Low: XXX on 2025-02-22
| Social Network | TikTok | X | News | YouTube | |
|---|---|---|---|---|---|
| Engagements | XXX | XXXXX | X | XX | XXX |
Mentions: XX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Month: XXX -XX%
6 Months: XXXXX +26%
1 Year: XXXXX +424%
1-Year High: XXX on 2025-08-13
1-Year Low: X on 2024-10-21
| Social Network | TikTok | X | News | YouTube | |
|---|---|---|---|---|---|
| Mentions | XX | XX | X | X | XX |
Creators: XX #
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Celltrion Inc. in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
1 Month: XX -XX%
6 Months: XXX +50%
1 Year: XXX +208%
1-Year High: XXX on 2025-07-23
1-Year Low: X on 2025-01-27
The most influential creators that mention Celltrion Inc. in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @JS_stockwatch | X | XXXXX | X | XX |
| @dliepau | X | XXXXX | X | XX |
| @RachelRachet | X | XXXXX | X | XX |
| @Celltrioninc | X | XXX | X | XX |
| @maybecha777 | X | XXX | X | X |
| @Philip__Went | X | XXXXX | X | X |
| @ej23ny | X | XXXXX | X | X |
Sentiment: XX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XX% -X%
6 Months: XX% -X%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-10-25
1-Year Low: XX% on 2025-02-03
Most Supportive Themes
- FDA Approval: (30%) Celltrion's Yuflyma gains FDA interchangeability, expanding market potential.
- US Biosimilar Expansion: (20%) Changes in US drug pricing could increase access to affordable medicines.
- Partnership With Abpro: (15%) Celltrion is investing and partnering with Abpro.
Most Critical Themes
- Engagement Decline & Negative Sentiment: (16%) Social media interest is declining, with a decrease in engagement.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| TikTok | XXX | X% | XXX | XX% | XX | X% |
| X | XXX | X% | XXXXX | XX% | X | X% |
| News | X | X% | X | X% | X | X% |
| XX | X% | XX | X% | X | X% | |
| YouTube | X | X% | XXX | X% | X | X% |
| Total | XXX | XX% | XXXXX | XX% | XX | X% |
Market Cap: $undefined #
Market Cap 24-Hour Time-Series Raw Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXXXXXX on 2024-12-18
1-Year Low: $XXXXXXXXXXXXXXXXXX on 2024-11-13
Top assets mentioned In the posts about Celltrion Inc. in the last XX hours
Eli Lilly and Company (LLY) Innovative Solutions & Support (ISSC) Amgen, Inc. (AMGN) Bitcoin Incognito (XBI) Piper Sandler Companies (PIPR) Gilead Sciences, Inc. (GILD) Thermo Fisher Scientific Inc. (TMO) Unilever plc (UL) ServiceNow Inc (NOW) Sanofi (SNY)
Top topics mentioned In the posts about Celltrion Inc. in the last XX hours
$abp, skincare, united states, stocks healthcare, eli, eli lilly, stocks, dual, approved, investment, japan, has been, liquid, money, launches, ronald, realworld, $issc, $156m, $175bn, $vape, $330m, momentum, balance sheet, $amgn, canada, south korea, targets, rachel, stocks technology, $091990kq, kosdaq, iv, price in, faster, lang, cancel, kung, kami, milky, abc news, dubai, demi, $idx, $pme, $pmeax, the only, future of, billion dollar, ipo, $175b, $30m, $xbi, half of, $wint, $pipr, spotlight, hasan, insider, victor, lisa, nasdaq, discussions, korea, malaysia, covid19, gilead sciences, $tmo, $4519t, $15m, $atnf, alan, $439b, $abcl, australia, samsung, paris, dedication, titan, long term, upside, corporate finance, $ul, $ulvrl, stocks consumer defensive, servicenow, sanofi, $azn, $mrk, $nvda, $apld, $robo, breakthrough, save the, #ai, united states dollar, $abbv, $pfe, danny, vida
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"The World's Most Innovative Companies of 2025 X. ServiceNow X. Workday X. Salesforce X. Tesla X. Amazon X. Netflix X. Incyte X. Unilever X. Naver XX. Facebook XX. Monster XX. Unilever Indonesia XX. Adobe XX. Celltrion XX. Autodesk XX. Regeneron XX. Vertex XX. AmorePacific XX. Concora XX. Illumina XX. Marriott International XX. Alexion XX. CP All XX. Red Hat XX. Tencent Source: Forbes"
X Link @TheDataHubX 2025-10-19T05:48Z 17.9K followers, 7109 engagements
"Hansoh and Leads Biolabs bag global outlicensing deals. Chugais partner Lilly announced positive P3 result for orforglipron. Celltrion launched Actemra biosimilar in US"
X Link @Generic_Tina 2025-10-19T00:35Z XX followers, XX engagements
"$ABP closed XXXXXX (+0.85%) vol 880.3K. The HER2CD3 bispecific engager ABP-102 shows best-in-class potential and Abpros strategic collaboration with Celltrion underpins its early-stage value narrative. Strategy postedclick to access full layout:"
X Link @JS_stockwatch 2025-10-18T23:43Z XXX followers, XX engagements
"$ABP strengthens biotech partnerships 🚀🚀🚀 Collaborations with Celltrion and other global pharma firms expand Abpros reach in antibody co-development and commercialization. 👉Only insiders get alerts join before it spikes 🔗"
X Link @EgrandeBilli 2025-10-18T01:04Z XXX followers, XX engagements